Campbell & CO Investment Adviser LLC Acquires New Position in Humana Inc. $HUM

Campbell & CO Investment Adviser LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,691 shares of the insurance provider’s stock, valued at approximately $700,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Blue Trust Inc. raised its position in shares of Humana by 3.6% during the 2nd quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock worth $334,000 after purchasing an additional 48 shares during the period. Private Wealth Management Group LLC grew its position in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares during the last quarter. Ossiam increased its holdings in shares of Humana by 1.6% in the 2nd quarter. Ossiam now owns 4,375 shares of the insurance provider’s stock worth $1,070,000 after acquiring an additional 71 shares during the period. MassMutual Private Wealth & Trust FSB lifted its position in Humana by 15.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 518 shares of the insurance provider’s stock valued at $135,000 after purchasing an additional 71 shares during the last quarter. Finally, Signaturefd LLC boosted its stake in Humana by 4.7% during the 3rd quarter. Signaturefd LLC now owns 1,626 shares of the insurance provider’s stock valued at $423,000 after purchasing an additional 73 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on HUM shares. Wells Fargo & Company cut Humana from an “overweight” rating to a “cautious” rating in a report on Wednesday, January 7th. Robert W. Baird cut their target price on Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a research note on Thursday, December 11th. Morgan Stanley reissued an “underperform” rating on shares of Humana in a research note on Thursday, December 18th. KeyCorp reaffirmed a “sector weight” rating on shares of Humana in a report on Friday, December 12th. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $344.00 target price on shares of Humana in a research note on Tuesday, January 6th. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $293.37.

Humana Stock Performance

Shares of HUM opened at $268.12 on Wednesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The firm’s 50 day moving average is $256.52 and its 200-day moving average is $264.22. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The stock has a market capitalization of $32.25 billion, a P/E ratio of 25.13, a P/E/G ratio of 2.25 and a beta of 0.45.

Humana (NYSE:HUM) last released its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating the consensus estimate of $2.95 by $0.29. The business had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the business earned $4.16 earnings per share. Equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio is currently 33.18%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.